Ours is a multidisciplinary group made up of 20 researchers from various fields and disciplines. The group originated in 1999 with the DAPGA study that was carried out at the Gavà Mental Health Center and the ABS Bartomeu Fabrés Anglada de Gavà. As a result of that first collaboration, others emerged that focused mainly on the evaluation of interventions aimed at the management of mental illnesses in PA, always with the economic evaluation component of these interventions. During the last years, the focus of research has increasingly specialized in the economic evaluation of health in PA, including the evaluation of the economic impact of diseases (e.g. COSTDEP), the cost-effectiveness of preventive interventions (e.g. PREDICTD-CCRT (4R09/043), PREDICT-WORK (4R18/092) PREDICTPLUSPREVENT (4R18/179)), pharmacological (INFAP (4R11/055)) and non-pharmacological (EUDAIMON (4R15/051) ), the cost of non-adherence both in the adult population (NON-INITIATORS (4R14/073)) and in the pediatric population (PEDIATRIC NON-INITIATORS (4R18/180)), etc. In addition, although the study of mental illness is still one of the main focuses of the group, research has expanded to other pathologies, such as chronic pain management and fibromyalgia (e.g. FIBROMYALGIA SUBTYPE (4R12/066) , EUDAIMON (4R15/051), ULTREYA (4R19/003) and IMPACT (FIS PI19/00112)), multi-risk prevention (Econ-EIRA3 (4R15/044)) or the design of interventions to improve the initiation of cardiovascular treatments and diabetes (NON-INITIATORS PHASE 1 (4R18/007), NON-INITIATORS CARDIOVASCULAR (4R18/172), NON-INITIATORS PHASE 2). The group complements the use of clinical trials and economic evaluations with other study designs that allow it to better understand the difficulties of managing pathologies in primary care and the efficiency of treatments, such as qualitative research (e.g. QUALIFAR (4R10/003); PREDICT-EVAL (4R12/046); NON-INITIATORS PHASE 1 (4R18/007), MENTAL HEALTH DIAGNOSIS of some Catalan counties and cities (4R17/125) systematic reviews (e.g. EIRA2 (4R12/048)), and epidemiological studies based on the secondary exploitation of large databases, such as SIDIAP (e.g. VORTIOXETINE PASS (4R18/004), all within the framework of research in the field of primary care, but with usual collaborations with the hospital.
Some of the group’s researchers are part of redIAPP, others are associate university professors at the Universitat Autònoma de Barcelona, ??the University of Barcelona or the Open University of Catalonia. And one of the researchers is a member of the European Depression Association and the Mental Health Group of the Wonca Working Party on Mental Health.
